Each month, thousands of patients on the cholesterol drug are switching to simvastatin, a cheaper alternative, but Pfizer is not letting its flagship drug go down without a fight.
From: www.nytimes.com
Maker of Lipitor Digs In to Fight Generic Rival
Posted by Ruslan Abuzant at 7:09 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment